Header Logo

Connection

RADEK SKODA to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications RADEK SKODA has written about Protein Kinase Inhibitors.
RADEK SKODA
Connection Strength
0.282
Protein Kinase Inhibitors
  1. Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity. J Med Chem. 2024 Jun 27; 67(12):10012-10024.
    View in: PubMed
    Score: 0.166
  2. Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms. J Clin Invest. 2019 03 04; 129(4):1596-1611.
    View in: PubMed
    Score: 0.115
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.